Sources | Names Used |
---|---|
CTRPv2 | BRD-K07442505 |
PharmacoGx | BRD-K07442505 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DNALI1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | NDUFA3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | DAZAP2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | ACSM1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | NR2F6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | CXorf56 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | CD200R1L | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | RP11-201K10.3 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | ZNF112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | CENPA | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |